Features | Cases | HE4 | ANXA2 | ||||
---|---|---|---|---|---|---|---|
Positive cases | Positive rate (%) | P | Positive cases | Positive rate (%) | P | ||
Pathological type | Â | Â | Â | Â | Â | Â | Â |
Mucinous | 20 | 17 | 85.00 | =0.53 | 18 | 90.00 | =0.12 |
Serous | 30 | 22 | 73.33 | Â | 20 | 66.67 | Â |
FIGO stage | Â | Â | Â | Â | Â | Â | Â |
I-II | 32 | 21 | 65.63 | = 0.01 | 21 | 65.63 | = 0.05 |
III-IV | 18 | 18 | 100.00 | Â | 17 | 94.44 | Â |
Differentiation | Â | Â | Â | Â | Â | Â | Â |
Well | 18 | 8 | 44.44 | = 0.003* <0.01** | 7 | 38.89 | = 0.003# <0.01## |
Moderate | 15 | 14 | 93.33 | 14 | 93.33 | ||
Poor | 17 | 17 | 100.00 | 17 | 100.00 | ||
Lymphatic metastasis | Â | Â | Â | Â | Â | Â | Â |
No | 30 | 19 | 63.33 | = 0.04 | 18 | 60.00 | =0.03 |
Yes | 12 | 12 | 100.00 | Â | 12 | 100.00 | Â |
Unknown | 8 | 8 | Â | Â | 8 | Â | Â |